MIST Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Milestone Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 0.7642 USD -1.95% Market Closed

Market Cap: $95.1m

	Milestone Pharmaceuticals Inc NASDAQ:MIST	CA
	Cenergy Holdings SA F:9CN	BE
A	Asta Co Ltd KOSDAQ:246720	KR

Profitability Summary

Milestone Pharmaceuticals Inc's profitability score is 5/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

32%

Sustainable 3Y Average Gross Margin

11%

Negative Operating Margin

-3,345%

Negative 3Y Average Operating Margin

-4,283%

Declining Operating Margin

-1,357% > -3,345%

Negative Net Margin

-3,586%

Negative 3Y Average Net Margin

-4,366%

Declining Net Margin

-1,317% > -3,586%

Negative Free Cash Flow Margin

-2,631%

Negative 3Y Average Free Cash Flow Margin

-3,341%

Declining Free Cash Flow Margin

-1,104% > -2,631%

Negative ROE

-35,523%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-1,790%

Declining ROIC

-809% > -4,314%

View All

Hide

Collapse

5 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.